Cargando…

Randomized Controlled Trial of Solriamfetol for Excessive Daytime Sleepiness in OSA: An Analysis of Subgroups Adherent or Nonadherent to OSA Treatment

BACKGROUND: Solriamfetol, a dopamine-norepinephrine reuptake inhibitor, is approved in the United States to improve wakefulness in adults with excessive daytime sleepiness (EDS) associated with OSA (37.5-150 mg/d). RESEARCH QUESTION: Does solriamfetol have differential effects on EDS based on adhere...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schweitzer, Paula K., Mayer, Geert, Rosenberg, Russell, Malhotra, Atul, Zammit, Gary K., Gotfried, Mark, Chandler, Patricia, Baladi, Michelle, Strohl, Kingman P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Chest Physicians 2021
Materias:	Sleep: Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411452/ https://www.ncbi.nlm.nih.gov/pubmed/33631141 http://dx.doi.org/10.1016/j.chest.2021.02.033

Ejemplares similares

Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof‐of‐Concept Trial
por: Videnovic, Aleksandar, et al.
Publicado: (2021)

Can postural OSA be usefully identified from its severity alone?
por: Johar, Aihem, et al.
Publicado: (2017)

Compliance after switching from CPAP to bilevel for patients with non-compliant OSA: big data analysis
por: Benjafield, Adam V, et al.
Publicado: (2019)

A randomized study of solriamfetol for excessive sleepiness in narcolepsy
por: Thorpy, Michael J., et al.
Publicado: (2019)

Coexistence of OSA may compensate for sleep related reduction in neural respiratory drive in patients with COPD
por: He, Bai-Ting, et al.
Publicado: (2017)

Effects of solriamfetol on on‐the‐road driving performance in participants with excessive daytime sleepiness associated with obstructive sleep apnoea
por: Vinckenbosch, Frederick, et al.
Publicado: (2022)

Long-term study of the safety and maintenance of efficacy of solriamfetol (JZP-110) in the treatment of excessive sleepiness in participants with narcolepsy or obstructive sleep apnea
por: Malhotra, Atul, et al.
Publicado: (2019)

The use of an online Epworth Sleepiness Scale to assess excessive daytime sleepiness
por: Boyes, Jennifer, et al.
Publicado: (2016)

Comparison of effects of OSA treatment by MAD and by CPAP on cardiac autonomic function during daytime
por: Glos, Martin, et al.
Publicado: (2015)

Excessive Daytime Sleepiness in Obstructive Sleep Apnea. Mechanisms and Clinical Management
por: Lal, Chitra, et al.
Publicado: (2021)

IMPACT OF COVID-19 INFECTION ON PATIENTS WITH OSA: A LONGITUDINAL STUDY
por: DAS, SAMARJIT
Publicado: (2022)

Integrated diagnostic pathway for patients referred with suspected OSA: a model for collaboration across the primary–secondary care interface
por: Devani, Nikesh, et al.
Publicado: (2020)

Management Of Excessive Sleepiness In Patients With Narcolepsy And OSA: Current Challenges And Future Prospects
por: Sahni, Ashima S, et al.
Publicado: (2019)

Deglutition and respiratory patterns during sleep in the aged with OSAS
por: Sato, Kiminori, et al.
Publicado: (2018)

Comparing treatment effects of a convenient vibratory positional device to CPAP in positional OSA: a crossover randomised controlled trial
por: Mok, Yingjuan, et al.
Publicado: (2020)

PAP treatment in patients with OSA does not induce long‐term nasal obstruction
por: Värendh, Maria, et al.
Publicado: (2018)

OBESITY HYPOVENTILATION SYNDROME, OSA, AND COVID-19 INFECTION IN A YOUNG MALE
por: DENOPOL, R.M., et al.
Publicado: (2022)

Profile of Solriamfetol in the Management of Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea: Focus on Patient Selection and Perspectives
por: Abad, Vivien C
Publicado: (2021)

P147 Solriamfetol Titration & AdministRaTion (START): Characteristics of patients with obstructive sleep apnoea (OSA) and prescriber rationale for starting treatment with solriamfetol
por: Singh, H, et al.
Publicado: (2021)

New perspective on exploring the predictive factors of blood pressure reduction during CPAP treatment in people with severe OSA and hypertension: a prospective observational study
por: Meng, Zili, et al.
Publicado: (2023)

Association of obstructive sleep apnoea with long-term cardiovascular events in patients with acute coronary syndrome with or without hypertension: insight from the OSA-ACS project
por: Wang, Ge, et al.
Publicado: (2023)

Update on Oral Appliance Therapy for OSA
por: Marklund, M.
Publicado: (2017)

Correlations between objective and subjective outcomes after adenotonsillar surgery in children with OSA
por: Sjölander, Isabella, et al.
Publicado: (2022)

O004 The effect of treating OSA with CPAP on mood and sleepiness
por: Tolson, J, et al.
Publicado: (2023)

Correlates of excessive daytime sleepiness in obstructive sleep apnea: Results from the nationwide SESAR cohort including 34,684 patients
por: Ulander, Martin, et al.
Publicado: (2022)

Relationship between sleep efficacy endpoints and measures of functional status and health‐related quality of life in participants with narcolepsy or obstructive sleep apnea treated for excessive daytime sleepiness
por: Weaver, Terri E., et al.
Publicado: (2020)

Sleep Study and Oximetry Parameters for Predicting Postoperative Complications in Patients With OSA
por: Suen, Colin, et al.
Publicado: (2019)

Night-to-Night Variability of Polysomnography-Derived Physiologic Endotypic Traits in Patients With Moderate to Severe OSA
por: Strassberger, Christian, et al.
Publicado: (2023)

The Role of Aldosterone in OSA and OSA-Related Hypertension
por: Wang, Yi, et al.
Publicado: (2022)

Excessive Daytime Sleepiness in Parkinson’s Disease
por: Liu, Hanshu, et al.
Publicado: (2022)

Gender differences in the sleep variables contributing to excessive daytime sleepiness among patients with obstructive sleep apnea
por: Honig, Eliya, et al.
Publicado: (2021)

Burden of Comorbidities in Patients with OSAS and COPD-OSAS Overlap Syndrome
por: Voulgaris, Athanasios, et al.
Publicado: (2021)

OSA Is Associated With the Human Gut Microbiota Composition and Functional Potential in the Population-Based Swedish CardioPulmonary bioImage Study
por: Baldanzi, Gabriel, et al.
Publicado: (2023)

Epidemiology, Physiology and Clinical Approach to Sleepiness at the Wheel in OSA Patients: A Narrative Review
por: Bonsignore, Maria R., et al.
Publicado: (2022)

Pathogenesis of obstructive sleep apnea in individuals with the COPD + OSA Overlap syndrome versus OSA alone
por: Orr, Jeremy E., et al.
Publicado: (2020)

P085 OSA-Onset: An algorithm for predicting the age of OSA onset
por: Olaithe, M, et al.
Publicado: (2022)

Excessive daytime sleepiness among depressed patients
por: Mume, Celestine Okorome
Publicado: (2010)

Internet addiction and excessive daytime sleepiness in adolescents
por: Semenova, N., et al.
Publicado: (2021)

Age, gender, neck circumference, and Epworth sleepiness scale do not predict obstructive sleep apnea (OSA) in moderate to severe chronic obstructive pulmonary disease (COPD): The challenge to predict OSA in advanced COPD
por: Soler, Xavier, et al.
Publicado: (2017)

Nasal resistance and OSA
por: Neto, Levon Mekhitarian
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ga2vkukqq4fb2b3t96ef8hcb1u